Telix reports fourth consecutive quarter of positive operating cash flow

/PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today issues its Appendix 4C quarterly cash flow report and accompanying...

Related Keywords

Switzerland ,China ,Australia ,Brazil ,Canada ,Melbourne ,Victoria ,United States ,United Kingdom ,Japan ,Belgium ,New Zealand ,Germany ,Chinese ,Australian ,Japanese ,Christian Behrenbruch ,Cdx Illuccix Clinicaltrials ,Prnewswire Telix ,Kyahn Williamson ,Merck Kga ,European Union ,Australian Securities Exchange ,Telix Pharmaceuticals ,Access Program ,Drug Administration ,Merck Kgaa ,Australian Therapeutic Goods Administration ,Party Transactions ,Health Canada ,Devices Agency ,Activities Report ,Telix Innovations ,Biologics License Application ,New Drug Application ,United States Food ,Medical Devices Agency ,Asia Pacific ,Breakthrough Therapy ,Expanded Access Program ,Greater China ,Grand Pharmaceutical Group Limited ,Non Executive Director Dr Andreas Kluge ,Managing Director ,Marketing Authorisation Applications ,Communications Email ,Limited Disclosure ,Telix Pharmaceuticals Limited ,